CandaceBavetteMainorMD

Oncology • Baltimore, MD

Physician

Join to view full profile

Dr. Mainor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mainor's full profile

Already have an account?

Office
22 S Greene St
Room N3e09
Baltimore, MD 21201
Phone+1 410-328-6110

Education & Training

University of MarylandResidency, Internal Medicine, 2012 - 2015
University of Maryland School of MedicineClass of 2012

Certifications & Licensure

DC State Medical License 2018 - 2027
MD State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery Start of enrollment: 2018 Oct 08
Terminated
Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancer.
Anna Northrop, Anika Christofferson, Saumya Umashankar, Michelle Melisko, Paolo Castillo
Journal of the American Medical Informatics Association. 2025-01-01
Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study.
Ilana Schlam, D Max Smith, Cody Peer, Tristan Sissung, Keith T Schmidt
NPJ Breast Cancer. 2024-09-30
Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA study.
Sandra Swain, Ilana Schlam, D Max Smith, Cody Peer, Tristan Sissung
Research Square. 2024-08-13

Press Mentions

Triple-Negative Breast Cancer Treatments Continue to EvolveNovember 25th, 2020
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and EquityApril 30th, 2024